FDA Investigator Sylvia A Thomas
Sylvia A Thomas has inspections in 1 countries as of 02 Nov 2023. Sylvia A Thomas has collaborated with a combined 1663 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
02 Nov 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Aimee K Contreras,
Alexandra B Pitkin,
Ali Hernandez,
Aliza Chalapong Asawesna,
Alyssa T Juguilon,
Alyssa T Vasquez,
Amelia N Tetterton,
Andy B Lee,
Angela Shepas,
Angelica G Aziz,
Carr Sharpe,
Cathryn M Groehnert,
Celena Ngo,
Christina D Mello,
Christophe L Boulmay,
Comyar Shoghi,
Cori W Bitterman,
Cristina E Mosquera,
Darrin E Davis,
David C Thomas,
David Serrano,
Davis,
Debbie K Giang,
Deborah W Hsu,
Debra C Yamane,
Debra D Devlieger,
Debra J Fracassa,
Denise H Howell,
Dennis N Hoang,
Desiree C Iya,
Diane R Lirhus,
Doretha M Wilson,
Dyana K Stone,
Eileen T Dupont,
Ellen N Stewart,
Eric Leung,
Erik D Sandvig,
Erik M Slama,
Fe Q Reyes,
Francisco,
Gene Matienzo,
Geraldine M Peregrin,
Gordon Chu,
Greg K Keshishyan,
Henry E Carrillo,
Herminio C Francisco,
Hoover,
Jane G Choi,
Jeff M Uriarte,
Jessica L Andrade,
John R Myung,
Joseph C Francisco,
Joseph C Yen,
Joseph H Lam,
Juan J Casado,
Judy C Nepsa,
Ka L Wong,
Katherine E Jacobitz,
Keeshunna D Daniels,
Kevin Lee,
Kevin N Tran,
Kevin T Gerrity,
Khang K Pham,
Kimberly M Lichter,
Lilly O Barton,
Ling Yul Liu,
Lourdes M Countee,
Matthew C Kristof,
Maurice M Sheehan,
Michael D Garcia,
Michael F Schuette,
Natalie J Ayoub,
Naveen B Walker,
Nianna C Burns,
Nicholas J Lahey,
Patricia F Alberico,
Phillip L Toy,
Richard C Chiang,
Robert C Hoover,
Rochelle A Rolnik,
Romero,
Ruben G Abrajano,
Sandersk,
Sara Jdent Acosta,
Sean P Desbrow,
Sorana Black,
State Agency,
Sundy Ven,
Takiyah S Gilmore Embery,
Tamara L Alexander,
Tanya E Malais,
Terrance L Thomas,
Terrance P Nguyen,
Thao T Kwan,
Tony J Wu,
Trushani T Desai,
Ve T Vuong,
Victoria C Yang,
Wayne L Jefferson,
Yolanda D Mitchell Lee,
Yvonne T Lacour
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more